Navigation Links
Kayentis Attended the Roundtable Discussion About HIT Adoption Organized By the Governor of Massachusetts
Date:12/7/2009

Philippe Berna, CEO of Kayentis, attended the roundtable discussion organized by Governor of Massachusetts Deval Patrick about the way to move quickly toward widespread HIT adoption.

(PRWEB) December 5, 2009 -- Philippe Berna, CEO of Kayentis, attended the roundtable discussion organized by Governor of Massachusetts Deval Patrick about the way to move quickly toward widespread HIT adoption.

Provider of secure integrated software solutions for capture, digitalization and management of handwritten data, Kayentis targets the Healthcare and Life Sciences market, by offering to manage clinical and marketing data, focusing on patient. Kayentis is a French company, member of System@TIC, Medicen, Pennsylvania BIO and BIO New Jersey clusters, with offices in France and in the USA (Philadelphia).

Kayentis solutions are partly based on research and development activities conducted by Hewlett Packard & Hitachi, partly based on Anoto Digital Pen & Paper technology. They combine the best that the physical and the digital world have to offer: the easiest data collection method for patients and physicians (pen & paper), offering the highest quality of data, combined with all the advantages of electronic data management (accurate timestamps, audit trail functionalities, real-time access, alerts, etc.). They are today the more efficient in terms of quick deployment and costs management.

As part of the reform of the healthcare system which is conducted currently by the US government, Philippe Berna, Kayentis CEO, attended a roundtable discussion with Governor of Massachusetts, Deval Patrick. The aim of this meeting was to discuss how to promote a widespread HIT adoption. It showed that software solutions can be a real accelerator for the healthcare plan by improving patient care while managing health care costs.

Philippe Berna presented first the two French clusters, System@TIC and Medicen, and their joint actions for innovative solutions which are focused on patients, by enhancing the value of innovative SBE presence, and their will to be established locally. Philippe Berna took part to the discussion by reminding that to get quickly a high adoption rate, it is essential to promote very simple and intuitive devices to connect naturally and rapidly people (patients, doctors, family, social): Pen and paper, thanks to their simplicity and conviviality are today the best path to not exclude anybody and to provide a rapid growth in HIT implementation. Providing real-time access to very high quality patient data, their solutions promote epidemiological database, allowing an acceleration of research.

In terms of health and social follow-up of patients (home care and services management), Kayentis solutions provide advanced functionalities. They promote patient protection by allowing the collection of patients consents in a secured and anonymous way and by offering the possibility to send real-time alerts in case of adverse event concludes Philippe Berna.

About Kayentis:
Kayentis provides software solutions to collect, display, share and archive information and clinical data. Kayentis Clin'Form solution, enabling Anoto functionality, is the optimal paper-based e-data capture solution for clinical trials. Clin'Form has been successfully deployed in studies conducted in more than 40 countries, involving over 50,000 patients across all continents.

Kayentis is a member of Pennsylvania BIO and BIO New Jersey. Kayentis is an Anoto Platinum Partner, an Oracle Partner and an HP Solution Business Partner. To discover more about Kayentis and its solutions please visit www.kayentis.com.

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3293584.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Kayentis, the Leading Provider of the Unique "Paper-Based e-Trial" Solution, has been Retained for Six New Clinical Studies in the US Market
2. On World AIDS Day, Russell Simmons and Special Guests Attended Empowerment for Africa Dinner
3. Stevens Health, Technology and Society roundtable: Sept. 19
4. NFIB Joins AARP, Business Roundtable and SEIU in Divided We Fail
5. Lucian Leape Institute Announces First Roundtable
6. OIG and HCCA Issue Government-Industry Roundtable Report
7. Lucian Leape Institute First Roundtable: A Resounding Success
8. Remarks By President Bush and President Kikwete of Tanzania at Roundtable on Pepfar
9. BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference
10. Genomic Health to Participate in Leerink Swann Roundtable Conference
11. Privacy Experts Roundtable Report Will Highlight Privacy & Security Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... FL (PRWEB) , ... February 22, 2017 , ... Gevir, ... from deer antler velvet, announced its products are coming soon to Amazon.com, the world’s ... and Shelley Thomson as a means to develop an effective natural treatment for Shelley’s ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... its certification exam and eligibility requirements effective with the April 2017 testing period. ... 1995. , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, over ... not filling a prescription because they could not afford to pay for it. ... were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and nursing ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This premier nanoemulsified ... from the mouth into the bloodstream. Far outpacing the absorption speed ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... a contract to Quality Insights to help small practices in Delaware, New Jersey, ... Program, established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Feb. 22, 2017  Allergan plc (NYSE: AGN), ... be a Gold sponsor of the Alzheimer,s Foundation ... Tour." This tour commemorates AFA,s15 years of educating ... and programs. The tour will include AFA,s free ... and displays of the AFA Quilt to Remember. ...
(Date:2/22/2017)... Oncternal Therapeutics, Inc., a clinical-stage biotechnology ... common malignancies, today announced the closing of an ... to use the proceeds to further clinical development ... preclinical development of a new ROR1-targeted antibody-drug conjugate ... anti-ROR1 monoclonal antibody being developed to treat patients ...
(Date:2/22/2017)... NEW YORK , February 22, 2017 ... half of the 50 states in the U.S. have now legalized ... Brazil , Canada , ... , Portugal , Uruguay ... steps to legalize or decriminalize cannabis in the last two years. ...
Breaking Medicine Technology: